EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Target‐Based Antitubercular Drug Discovery: Scaffold Diversity and SAR Trends of Small Molecules Against Mycobacterium Tuberculosis

Rakesh Chandra Kalita iD, Kaustubh Ajit Kolekar iD, Sachin Kumar Singh iD, Deepshikha Patle iD

Archiv der Pharmazie · 2026

DOI: 10.1002/ardp.70347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Rakesh Chandra Kalita und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Drug Discovery. Die Arbeit nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis remains a major infectious disease, and the increasing incidence of multidrug‐resistant Mycobacterium tuberculosis continues to limit current treatment options. This review summarizes recent medicinal chemistry efforts directed toward six important M. tuberculosis targets: InhA, DprE1, MmpL3, QcrB, DNA gyrase, and dihydrofolate reductase (DHFR). Emphasis is placed on the structural diversity and biological activity of potent molecules. SAR analysis relates changes in scaffold, substituent pattern, linker geometry, lipophilicity, and polarity to antimycobacterial potency and activity against resistant strains. Selected synthetic routes and clinically relevant antitubercular compounds are also discussed. Selected docking studies provide supportive structural information for representative potent inhibitors, while comparative SAR analysis provides an overview of the major structural features associated with activity across the target classes. Overall, the review summarizes recent medicinal chemistry advances in targeted antitubercular drug discovery and provides SAR considerations for further lead optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsMycobacterium tuberculosisDrug DiscoveryStructure-Activity RelationshipHumansBacterial ProteinsDrug DesignMolecular StructureAnimalsTuberculosisOxidoreductases

Stichwörter der Autor:innen

anti‐tuberculosis agentsclinical translationdrug resistancemedicinal chemistrypharmacologytarget‐based drug discovery

Substanzen

Antitubercular AgentsBacterial ProteinsInhA protein, MycobacteriumOxidoreductases

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

ORCID-Profile: Rakesh Chandra Kalita, Kaustubh Ajit Kolekar, Sachin Kumar Singh, Deepshikha Patle

Zitieren

APA

Kalita, R. C., Kolekar, K. A., Singh, S. K., & Patle, D. (2026). Target‐Based Antitubercular Drug Discovery: Scaffold Diversity and SAR Trends of Small Molecules Against Mycobacterium Tuberculosis. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70347

Vancouver

Kalita RC, Kolekar KA, Singh SK, Patle D. Target‐Based Antitubercular Drug Discovery: Scaffold Diversity and SAR Trends of Small Molecules Against Mycobacterium Tuberculosis. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70347

BibTeX
@article{Kalita2026,
  author = {Kalita, Rakesh Chandra and Kolekar, Kaustubh Ajit and Singh, Sachin Kumar and Patle, Deepshikha},
  title = {Target‐Based Antitubercular Drug Discovery: Scaffold Diversity and SAR Trends of Small Molecules Against Mycobacterium Tuberculosis},
  journal = {Archiv der Pharmazie},
  year = {2026},
  doi = {10.1002/ardp.70347}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche